Extracellular matrix as a solid-state regulator in angiogenesis: identification of new targets for anti-cancer therapy.
Angiogenesis, the growth of blood capillaries, is regulated by soluble growth factors and insoluble extracellular matrix (ECM) molecules. Soluble angiogenic mitogens act over large distances to initiate capillary growth whereas changes in ECM govern whether individual cells will grow, differentiate, or involute in response to these stimuli in the local tissue microenvironment. Analysis of this local control mechanism has revealed that ECM molecules switch capillary endothelial cells between differentiation and growth by both binding specific transmembrane integrin receptors and physically resisting cell-generated mechanical loads that are applied to these receptors. Control of capillary endothelial cell form and function therefore may be exerted by altering the mechanical properties of the ECM as well as its chemical composition. Understanding of this mechanochemical control mechanism has led to the development of new angiogenesis inhibitors that may be useful for the treatment of cancer.
Ingber
D E
DE
Department of Surgery, Children's Hospital, Boston, MA 02115.
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D001485:Basement Membrane / Q000502:physiology; D002196:Capillaries / Q000648:ultrastructure; D002453:Cell Cycle; D015195:Drug Design; D004730:Endothelium, Vascular / Q000648:ultrastructure; D005109:Extracellular Matrix / Q000502:physiology*; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D016023:Integrins / Q000502:physiology; D009024:Morphogenesis; D009369:Neoplasms / Q000098:blood supply* / Q000188:drug therapy / Q000473:pathology; D009389:Neovascularization, Pathologic / Q000503:physiopathology*; D015398:Signal Transduction
D000970:Antineoplastic Agents; D016023:Integrins